Skip to main content
Clinical Trials/NCT02776020
NCT02776020
Unknown
N/A

Non-invasive, Real-time Anesthetic Drug-monitoring System

Rambam Health Care Campus0 sites30 target enrollmentJune 2016
ConditionsAnesthesia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anesthesia
Sponsor
Rambam Health Care Campus
Enrollment
30
Primary Endpoint
Changes in Propofol Blood Levels
Last Updated
9 years ago

Overview

Brief Summary

The aim of this study is to determine efficacy of the "CorrecDose" device to continuously and non-invasively follow the changes in propofol concentrations in the participants' blood.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
February 2017
Last Updated
9 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

ABECASSIS PHILIPPE

Head of women and obstetrics anesthesiology unit

Rambam Health Care Campus

Eligibility Criteria

Inclusion Criteria

  • Women who have signed Informed consent form
  • Women undergoing Trans vaginal ovum retrieval (TVOR) for invitro fertilization (IVF) and will be sedated with propofol administered intravenos (IV)

Exclusion Criteria

  • Women with background diseases
  • Women with chronic use of drug and medication
  • Women with peripheral blood vessels problems
  • Women with high blood pressure
  • Women with body mass index (BMI) score over 35 or less than 18

Outcomes

Primary Outcomes

Changes in Propofol Blood Levels

Time Frame: Half hour

Graphic display on monitor of real-time changes

Similar Trials